Hematology
Latest News
Unexpected thrombocytosis could flag occult cancer
The risk was highest (23.3 times) for ovarian cancer. The risk was 3.8 times higher for pancreatic cancer and 3.5 times higher for cervical cancer...
Latest News
CVST after COVID-19 vaccine: New data confirm high mortality rate
“This is the biggest series, and as an international series, it gives a broader perspective from a larger range of countries.”
From the Journals
Study gives bleeding risk estimates for VTE patients on anticoagulants
New research provides best available estimates of long-term bleeding risk with different anticoagulants, authors say.
Latest News
Iron deficiency in pregnancy is common, yet many aren’t being screened for it
Researchers found that only 59.4% of pregnant persons received an iron test, and 71% of these tests were ordered during the first trimester, when...
From the Journals
Sickle cell disease, trait may up risk for poor COVID outcomes
Even those who carry just one copy of the sickle cell gene – the carrier status for sickle cell disease – appeared to be at heightened risk.
Myth of the Month
Does optimal iron absorption include vitamin C?
Plus, how often should a patient with iron deficiency take oral iron supplementation?
From the Journals
Infusion centers may best EDs for treating sickle cell crises
At infusion centers, patients received pain medication an average of 70 minutes faster compared with patients treated in EDs.
News
CDC notes sharp declines in breast and cervical cancer screening
The new data come from the National Breast and Cervical Cancer Early Detection Program, which provides cancer screening services to women with low...
From the Journals
Reversal agents curb DOAC-related bleeding but deaths still high
The meta-analysis of more than 4,000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.
From the Journals
First year of life sees initial bleeding episodes in children with von Willebrand disease
From the Journals
Patients with CLL have significantly reduced response to COVID-19 vaccine
Less than half of CLL patients had an antibody-mediated response to the Pfizer vaccine in a study.